Ourania Tatsis - Feb 24, 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Feb 24, 2022
Transactions value $
-$665,215
Form type
4
Date filed
2/28/2022, 04:27 PM
Previous filing
Feb 22, 2022
Next filing
Mar 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability -$590K -2.59K -4.88% $227.86 50.5K Feb 24, 2022 Direct
transaction VRTX Common Stock Sale -$6.41K -28 -0.06% $228.88 50.5K Feb 25, 2022 Direct F1, F2, F3
transaction VRTX Common Stock Sale -$17.7K -77 -0.15% $230.26 50.4K Feb 25, 2022 Direct F1, F3, F4
transaction VRTX Common Stock Sale -$26.6K -115 -0.23% $230.97 50.3K Feb 25, 2022 Direct F1, F3, F5
transaction VRTX Common Stock Sale -$20.2K -87 -0.17% $231.81 50.2K Feb 25, 2022 Direct F1, F3, F6
transaction VRTX Common Stock Sale -$4.19K -18 -0.04% $232.80 50.2K Feb 25, 2022 Direct F1, F3, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Ms. Tatsis' company approved trading plan under Rule 10b5-1.
F2 Open market sales reported on this line occurred at a weighted average price of $228.88 (range $228.39 to $229.36).
F3 Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F4 Open market sales reported on this line occurred at a weighted average price of $230.26 (range $229.50 to $230.48).
F5 Open market sales reported on this line occurred at a weighted average price of $230.97 (range $230.50 to $231.47).
F6 Open market sales reported on this line occurred at a weighted average price of $231.81 (range $231.52 to $232.31).
F7 Open market sales reported on this line occurred at a weighted average price of $232.80 (range $232.59 to $232.92).